chronic hepatitis B virus infection

July 19, 2016July 19, 2016

Investigational RNAi Therapy for Chronic Hepatitis B Starts Phase 1/2 Trial

Hepatitis B, News

A new RNAi treatment candidate for chronic hepatitis B (HBV) infection called ALN-HBV, has entered a Phase 1/2 clinical trial to evaluate its safety and efficacy in healthy volunteers and HBV ... Read more

December 15, 2015December 15, 2015

New Chronic Hepatitis B Treatment Available in Cuba

Hepatitis B, News

ABIVAX and the Center for Genetic Engineering and Biotechnology (CIGB) announced that Cuban regulatory authorities have granted their first marketing authorization application for ABX203 (HeberNasvac), a first-in-class vaccine to treat chronic ... Read more

June 18, 2015June 18, 2015

Hepatitis B Vaccine Less Effective In Patients With Rheumatoid Arthritis

News

Results recently presented during the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference demonstrated that patients suffering with rheumatoid arthritis (RA) are less likely to become protected by the hepatitis B vaccine when compared to the general population. ... Read more

April 30, 2015April 30, 2015

Study Reveals Hepatitis E Vaccine Can Protect Up to 4.5 Years

Hepatitis E, News

A new study conducted by a research group in China assessed a vaccine for Hepatitis E. The vaccine caused the production of antibodies and protected vaccine recipients from hepatitis E for up to ... Read more

April 22, 2015April 22, 2015

Cancer Drugs Being Tested To Combat Chronic Hepatitis B

Hepatitis B

Australia is on the verge of becoming a pioneer in formulating a possible cure for chronic Hepatitis B infections and related complications, like cirrhosis and liver cancer. According to a recent press ... Read more

April 17, 2015April 17, 2015

Ichor, Janssen Announce Chronic Hepatitis B Immunotherapies Delivered With TriGrid Electroporation Device

Hepatitis B, News

Ichor Medical Systems (Ichor) recently announced it has joined a product advancement collaboration and license agreement with Janssen Pharmaceuticals (Janssen). Both parties will be working together to advance and market DNA-based vaccine products to ... Read more

March 23, 2015March 23, 2015

Three New Executive Members Join Tekmira to Address Hepatitis B

Hepatitis B, News

Biopharmaceutical company Tekmira Pharmaceuticals Corporation has appointed three new executive members to support their mission of finding a cure for chronic hepatitis B virus infection (HBV). The new senior vice president of ... Read more

March 3, 2015March 3, 2015

HBV Patients With Nucleotide Analogue Resistance May Benefit from TDF Monotherapy

Hepatitis B, News

Recent research reports that tenofovir disoproxil fumarate (TDF) therapy for long periods is efficient in Chinese patients with chronic hepatitis B virus (HBV) infection that have relapsed after therapy with multiple ... Read more

February 17, 2015February 17, 2015

Study Reveals That Chemotherapy or Immunosuppressive Treatment May Reactivate HBV

Hepatitis B, News

A new review on the effect of Chemotherapy or immunosuppressive therapy in reactivation of Hepatitis B virus infection entitled “Recent US Food and Drug Administration warnings on hepatitis B reactivation ... Read more

February 4, 2015February 5, 2015

Tekmira Begins Phase I Clinical Trial Of TKM-HBV For Hepatitis B

News

Tekmira Pharmaceuticals Corporation, a leading company in the development of RNA interference (RNAi) therapeutics, recently announced they have successfully dosed the first subject in a Phase I clinical trial of TKM-HBV – a therapeutic drug ... Read more